网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
食管癌相关风险因素的孟德尔随机化研究
作者:张闻烙1  刘广超1  蔡迎彬2  王岩3  王文翔1  朱琳4 
单位:1. 新疆医科大学 公共卫生学院, 新疆 乌鲁木齐 830011;
2. 新疆医科大学附属肿瘤医院 内镜诊疗中心, 新疆 乌鲁木齐 830011;
3. 新疆医科大学附属肿瘤医院 肿瘤防治办公室, 新疆 乌鲁木齐 830011;
4. 新疆医科大学 护理学院, 新疆 乌鲁木齐 830011
关键词:食管癌 风险因素 孟德尔随机化 孟德尔随机化-贝叶斯模型平均法 
分类号:R735.1
出版年·卷·期(页码):2025·53·第二期(187-196)
摘要:

目的: 基于孟德尔随机化方法探讨个体特征、饮食摄入及疾病相关等方面风险因素与食管癌之间的因果关系,为食管癌的早期预防提供依据。方法: 基于全基因组关联分析(Genome-wide association study,GWAS)获得与31个暴露因素相关的遗传变异数据,通过两样本孟德尔随机化方法及贝叶斯平均的多元孟德尔随机化方法(MR-BMA),分析与食管癌的因果风险因素,通过留一法、异质性检验、水平多效性检验、Q统计量和Cook距离验证结果的稳定性和可靠性。结果: 单元孟德尔随机化分析结果显示BMI (OR=1.000 9,95%CI:1.000 2~1.001 5)、吸烟(OR=1.007 9,95%CI:1.003 1~1.012 8)、胃食管反流病(OR=1.001 3,95%CI:1.000 5~1.002 1)及甲亢(OR=1.033 8,95%CI:1.007 1~1.061 2)会增加食管癌患病的风险,而受教育时间(OR=0.998 6,95%CI:0.997 6~0.999 6)及运动习惯(OR=0.990 2,95%CI:0.981 5~0.998 9)会降低食管癌患病风险,并且以上影响因素多效性检验结果显示不存在水平多效性。MR-BMA结果显示BMI (MIP=0.545)是因果证据最强的暴露因素,经验P=0.017,具有统计学意义,其它暴露因素的均无统计学意义。结论: BMI、吸烟、胃食管反流病及甲亢为食管癌的危险因素。受教育时间及运动习惯可能为食管癌的保护因素。其中BMI是一个独立的暴露因素,可能对其他暴露因素存在介导作用。

Objective: To explore the causal relationship between individual characteristics, dietary intake and disease-related risk factors and esophageal cancer based on Mendelian randomization, and to provide a basis for the early prevention of esophageal cancer. Methods: Based on Genome-wide association study(GWAS) to obtain genetic variant data associated with 31 exposure factors, the causal risk factors associated with esophageal cancer were analyzed by the unit two-sample Mendelian randomization method and the multivariate Mendelian randomization method with Bayesian averaging(MR-BMA) by leave-one-out method, heterogeneity test, horizontal multivariate test, Q statistic and Cook distance to verify the stability and reliability of the results. Result:The results of unitary Mendelian randomization analysis showed that BMI(OR=1.000 9, 95%CI:1.000 2~1.001 5), smoking(OR=1.007 9, 95%CI:1.003 1~1.012 8), gastroesophageal reflux disease(OR=1.001 3, 95%CI:1.000 5~1.002 1) and hyperthyroidism(OR=1.033 8, 95%CI:1.007 1~1.061 2) increased the risk of esophageal cancer, whereas the duration of education(OR=0.998 6, 95%CI:0.997 6~0.999 6) and physical activity habits(OR=0.990 2, 95%CI:0.981 5~0.998 9) decreased the risk of esophageal cancer. The results of multivariate test of the above influences showed no horizontal multivariate. the MR-BMA results showed that BMI(MIP=0.545) was the exposure factor with the strongest evidence of causality, with an empirical P=0.017, which was statistically significant, and no statistically significant results were found for any other exposure factors. Conclusion: BMI, smoking, GERD and hyperthyroidism may be risk factors for esophageal cancer. Level of education and exercise habits may be protective factors for esophageal cancer. Among them, BMI is an independent exposure factor and may have a mediating effect on other exposure factors.

参考文献:

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 郑荣寿,张思维,孙可欣,等.2016年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2023,45(3):212-220.
[3] CHEN R,MA S,GUAN C,et al.The national cohort of esophageal cancer-prospective cohort study of esophageal cancer and precancerous lesions based on high-risk population in China (ncec-hrp):study protocol[J].BMJ Open,2019,9(4):e027360.
[4] FENG X,HUA Z L,ZHOU Q,et al.Prevalence and coprevalence of modifiable risk factors for upper digestive tract cancer among residents aged 40-69 years in Yangzhong city,China:a cross-sectional study[J].BMJ Open,2021,11(4):e042006.
[5] 郑玉玲,张瑞,马纯政,等.食管癌饮食相关因素的流行病学调查[J].中医学报,2022,37(12):2577-2581.
[6] DAVEY S G,HEMANI G.Mendelian randomization:genetic anchors for causal inference in epidemiological studies[J].Hum Mol Genet,2014,23(R1):R89-R98.
[7] LARSSON S C,BUTTERWORTH A S,BURGESS S.Mendelian randomization for cardiovascular diseases:principles and applications[J].Eur Heart J,2023,44(47):4913-4924.
[8] LANDER S,LANDER E,GIBSON M K.Esophageal cancer:overview,risk factors,and reasons for the rise[J].Curr Gastroenterol Rep,2023,25(11):275-279.
[9] PENNATHUR A,GIBSON M K,JOBE B A,et al.Oesophageal carcinoma[J].Lancet,2013,381(9864):400-412.
[10] UHLENHOPP D J,THEN E O,SUNKARA T,et al.Epidemiology of esophageal cancer:update in global trends,etiology and risk factors[J].Clin J Gastroenterol,2020,13(6):1010-1021.
[11] XIE S H,LAGERGREN J.Risk factors for oesophageal cancer[J].Best Pract Res Clin Gastroenterol,2018,36-37:3-8.
[12] XU B,ZHOU X,LI X,et al.Diabetes mellitus carries a risk of esophageal cancer:a Meta-analysis[J].Medicine (Baltimore),2017,96(35):e7944.
[13] ZHANG J,ZHOU B,HAO C.Coffee consumption and risk of esophageal cancer incidence:a Meta-analysis of epidemiologic studies[J].Medicine (Baltimore),2018,97(17):e0514.
[14] XU J,ZHANG S,TIAN Y,et al.Genetic causal association between iron status and osteoarthritis:a two-sample Mendelian randomization[J].Nutrients,2022,14(18):3683.
[15] LIN Z,DENG Y,PAN W.Combining the strengths of inverse-variance weighting and egger regression in Mendelian randomization using a mixture of regressions model[J].PLoS Genet,2021,17(11):e1009922.
[16] BOWDEN J,HEMANI G,DAVEY S G.Invited commentary:detecting individual and global horizontal pleiotropy in Mendelian randomization-a job for the humble heterogeneity statistic?[J].Am J Epidemiol,2018,187(12):2681-2685.
[17] ZHENG J,BAIRD D,BORGES M C,et al.Recent developments in Mendelian randomization studies[J].Curr Epidemiol Rep,2017,4(4):330-345.
[18] BURGESS S,THOMPSON S G.Erratum to:interpreting findings from Mendelian randomization using the MR-Egger method[J].Eur J Epidemiol,2017,32(5):391-392.
[19] WU S,JIANG W,LI J,et al.Global burden of esophageal cancer attributable to smoking:a systematic analysis for the global burden of disease study 2019[J].Front Oncol,2023,13:1223164.
[20] 刘爱玲,周静静,李成程,等.1990-2019年中国归因于烟草的食管癌疾病负担趋势和死亡预测分析[J].中国全科医学,2023,26(36):4587-4594,4601.
[21] SCHERVBL H.Tobacco smoking and gastrointestinal cancer risk[J].Visc Med,2022,38(3):217-222.
[22] FREEDMAN N D,ABNET C C,LEITZMANN M F,et al.A prospective study of tobacco,alcohol,and the risk of esophageal and gastric cancer subtypes[J].Am J Epidemiol,2007,165(12):1424-1433.
[23] 范嘉俊,陶庆松,丁远,等.胃食管反流病诊断的研究进展[J].东南大学学报(医学版),2020,39(3):385-389.
[24] TRAN C L,HAN M,KIM B,et al.Gastroesophageal reflux disease and risk of cancer:findings from the Korean national health screening cohort[J].Cancer Med,2023,12(18):19163-19173.
[25] KAPOOR H,LOHANI K R,LEE T H,et al.Animal models of barrett's esophagus and esophageal adenocarcinoma-past,present,and future[J].Clin Transl Sci,2015,8(6):841-847.
[26] WANG S M,FREEDMAN N D,KATKI H A,et al.Gastroesophageal reflux disease:a risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the nih-aarp diet and health study cohort[J].Cancer,2021,127(11):1871-1879.
[27] SAADAAT R,ABDUL-GHAFAR J,HANIFI A N,et al.Risk factors associated with esophageal cancers,diagnosed at tertiary level in afghanistan:a descriptive cross-sectional study[J].BMC Cancer,2022,22(1):1112.
[28] ZHANG X,YANG X,ZHANG T,et al.Association of educational attainment with esophageal cancer,barrett's esophagus,and gastroesophageal reflux disease,and the mediating role of modifiable risk factors:a Mendelian randomization study[J].Front Public Health,2023,11:1022367.
[29] FRIEDENREICH C M,RYDER-BURBIDGE C,MCNEIL J.Physical activity,obesity and sedentary behavior in cancer etiology:epidemiologic evidence and biologic mechanisms[J].Mol Oncol,2021,15(3):790-800.
[30] LIN H Y,SU Y F,HSIEH M T,et al.Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone[J].FASEB J,2013,27(8):3209-3216.
[31] PETRANOVI O P,VERBURG F A,HOFFMANN M,et al.Higher thyroid hormone levels and cancer[J].Eur J Nucl Med Mol Imaging,2021,48(3):808-821.
[32] HELLEVIK A I,ASVOLD B O,BJØRO T,et al.Thyroid function and cancer risk:a prospective population study[J].Cancer Epidemiol Biomarkers Prev,2009,18(2):570-574.
[33] PATI S,IRFAN W,JAMEEL A,et al.Obesity and cancer:a current overview of epidemiology,pathogenesis,outcomes,and management[J].Cancers (Basel),2023,15(2):485.
[34] BHASKARAN K,DOUGLAS I,FORBES H,et al.Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5.24 million UK adults[J].Lancet,2014,384(9945):755-765.
[35] DIKAIOU P,EDQVIST J,LAGERGREN J,et al.Body mass index and risk of cancer in young women[J].Sci Rep,2024,14(1):6245.
[36] KAWACHI A,SHIMAZU T,BUDHATHOKI S,et al.Association of BMI and height with the risk of endometrial cancer,overall and by histological subtype:a population-based prospective cohort study in Japan[J].Eur J Cancer Prev,2019,28(3):196-202.
[37] LAUBY-SECRETAN B,DOSSUS L,MARANT-MICALLEF C,et al.Cancer[obesity and cancer][J].Bull Cancer,2019,106(7-8):635-646.
[38] WU G,LIU Y,NING D,et al.Unraveling the causality between gastroesophageal reflux disease and increased cancer risk:evidence from the UK biobank and gwas consortia[J].BMC Med,2024,22(1):323.
[39] CHEN Z,ZHANG X,ZHAI J,et al.Global burden of esophageal cancer attributable to high BMI in 204 countries and territories:1990-2019[J].Thorac Cancer,2024,15(9):681-692.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 878591 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541